Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Journal of Nanobiotechnology|July 6, 2022
IGF1 receptor-targeted black TiO<sub>2</sub> nanoprobes for MRI-guided synergetic photothermal-chemotherapy in drug resistant pancreatic tumorKaiwei Xu, Lufei Jin, Liu Xu, et al.
Translational Lung Cancer Research|January 9, 2026
A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II-IIIB non-small cell lung cancer patients with <i>EGFR</i> mutationYue Chen, Jiandong Mei, Ge Gao, et al.
ACS Nano|January 19, 2021
Metal-Free Organo-Theranostic Nanosystem with High Nitroxide Stability and Loading for Image-Guided Targeted Tumor TherapyOzioma U Akakuru, Chen Xu, Chuang Liu, et al.
Fundamental Research|August 19, 2024
Multiple valence states of Fe boosting SERS activity of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and enabling effective SERS-MRI bimodal cancer imagingJie Lin, Xuehua Ma, Anran Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 21, 2020
A Hybrid Organo-Nanotheranostic Platform of Superlative Biocompatibility for Near-Infrared-Triggered Fluorescence Imaging and Synergistically Enhanced Ablation of TumorsOzioma Udochukwu Akakuru, Chuang Liu, M Zubair Iqbal, et al.
Thoracic Cancer|September 19, 2017
Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case-control studyDaxian Luo, Meijuan Huang, Xinxing Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2021
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patientsChengzhi Cai, Yuan Tang, Yanying Li, et al.
Scientific Reports|October 1, 2020
PD-L1 expression is a promising predictor of survival in patients with advanced lung adenocarcinoma undergoing pemetrexed maintenance therapyYi Qin, Lili Jiang, Min Yu, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapyHongfei Wang, Yixuan Sun, Xiuman Zhou, et al.
Biomaterials|July 17, 2021
Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axisZhipeng Li, Fangqing Wang, Yanying Li, et al.
Pageof 19